Overview

A Study Evaluating the Bioavailability of Oral Insulin (N11005)

Status:
Completed
Trial end date:
2020-08-14
Target enrollment:
Participant gender:
Summary
The objective of this study was to preliminarily verify whether the oral insulin N11005 is a prandial insulin by assessing the PK, PD, and safety profiles of N11005.
Phase:
Phase 1
Details
Lead Sponsor:
Beijing Hospital
Treatments:
Insulin